Trial Profile
Factors related to non-adherence to lenalidomide in multiple myeloma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jun 2018
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Jun 2018 New trial record
- 05 Jun 2018 Results Factors related to non-adherence to lenalidomide, presented at the 54th Annual Meeting of the American Society of Clinical Oncology